StockData
Insulet Corp logo

Insulet Corp (PODD) stock

PODDNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 21/3048% below fair value
$139.98−5.36 (-3.69%)

Close on Nov 18, 2026Market cap $9.71BP/E 22.8Yield –

Insulet free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Insulet's free cash flow for the twelve months ending Sep 30, 2026 was $260.00M, down 38.6% year over year. For fiscal 2025 it was $377.70M, up 23.7% from the year before. The highest annual figure on record is $377.70M in fiscal 2025.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025$377.70M+23.7%
FY2024Dec 31, 2024$305.30M+335.5%
FY2023Dec 31, 2023$70.10M–
FY2022Dec 31, 2022-$3.90M–
FY2021Dec 31, 2021-$180.00M–
FY2020Dec 31, 2020-$45.00M–
FY2019Dec 31, 2019-$65.30M–
FY2018Dec 31, 2018-$121.50M–
FY2017Dec 31, 2017-$32.50M–
FY2016Dec 31, 2016-$6.20M–
FY2015Dec 31, 2015-$23.16M–
FY2014Dec 31, 2014-$2.57M–
FY2013Dec 31, 2013-$3.96M–
FY2012Dec 31, 2012-$40.05M–
FY2011Dec 31, 2011-$36.57M–
FY2010Dec 31, 2010-$42.17M–
FY2009Dec 31, 2009-$52.46M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$66.40M-33.7%
Q2 FY2026Jun 30, 2026$55.90M-68.6%
Q1 FY2026Mar 31, 2026$89.50M+73.8%
Q4 FY2025Dec 31, 2025$48.20M-48.7%
Q3 FY2025Sep 30, 2025$100.10M+22.7%
Q2 FY2025Jun 30, 2025$177.90M+176.7%
Q1 FY2025Mar 31, 2025$51.50M-21.4%
Q4 FY2024Dec 31, 2024$93.90M+490.6%
Q3 FY2024Sep 30, 2024$81.60M+127.3%
Q2 FY2024Jun 30, 2024$64.30M+127.2%
Q1 FY2024Mar 31, 2024$65.50M–
Q4 FY2023Dec 31, 2023$15.90M–
Q3 FY2023Sep 30, 2023$35.90M+40.2%
Q2 FY2023Jun 30, 2023$28.30M+164.5%
Q1 FY2023Mar 31, 2023-$10.00M–
Q4 FY2022Dec 31, 2022-$13.70M–
Q3 FY2022Sep 30, 2022$25.60M–
Q2 FY2022Jun 30, 2022$10.70M–
Q1 FY2022Mar 31, 2022-$26.50M–
Q4 FY2021Dec 31, 2021-$57.30M–
Q3 FY2021Sep 30, 2021-$53.10M-400.0%
Q2 FY2021Jun 30, 2021-$1.60M-200.0%
Q1 FY2021Mar 31, 2021-$68.00M–
Q4 FY2020Dec 31, 2020-$33.80M–
Q3 FY2020Sep 30, 2020$17.70M+110.7%
Q2 FY2020Jun 30, 2020$1.60M–
Q1 FY2020Mar 31, 2020-$30.50M–
Q4 FY2019Dec 31, 2019-$2.20M–
Q3 FY2019Sep 30, 2019$8.40M–
Q2 FY2019Jun 30, 2019-$33.60M–
Q1 FY2019Mar 31, 2019-$37.90M–
Q4 FY2018Dec 31, 2018-$2.11M–
Q3 FY2018Sep 30, 2018-$21.27M-246.4%
Q2 FY2018Jun 30, 2018-$58.49M-1378.4%
Q1 FY2018Mar 31, 2018-$39.64M–
Q4 FY2017Dec 31, 2017-$4.09M-123.9%
Q3 FY2017Sep 30, 2017$14.53M–
Q2 FY2017Jun 30, 2017$4.58M–
Q1 FY2017Mar 31, 2017-$47.51M–
Q4 FY2016Dec 31, 2016$17.16M–

More Insulet figures

See a number that looks wrong?